Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07488156

Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

The Impact of Health Literacy on the Attitudes Toward Pharmacological Treatment in Patients With Schizophrenia Spectrum Disorder

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Louisiana State University Health Sciences Center in New Orleans · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The Impact of Health Literacy on the Attitudes toward Pharmacological Treatment in Patients with Schizophrenia Spectrum Disorder This interventional study is aimed at: * assessing and improving the health literacy and * assessing the attitude towards treatment of patients with schizophrenia spectrum disorders while they are admitted to the inpatient psychiatric unit.

Detailed description

The study will take place at University Medical Center in New Orleans, LA and will include 34 patients with a schizophrenia spectrum disorder diagnosis who are admitted to the psychiatric unit. Participants will take tests to assess their knowledge of SSD before and after receiving educational materials during their hospitalization. They will also receive questionnaires assessing their attitudes toward treatment before and after the educational interventions. After each patient is provided with educational material, they will be allowed to ask the healthcare provider questions pertaining to schizophrenia. Following discharge, patients will be followed for a total of 12 months, where they will be called to answer questions about medication adherence.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEducational sessionsPatients will be given an educational pamphlet with information about schizophrenia spectrum disorders, including prognosis and management options. Following this, they will be allowed to ask the doctor any questions they have pertaining to schizophrenia spectrum disorder. In the second educational session, patients will watch a video containing information about schizophrenia spectrum disorders. Following this, they will be allowed to ask the doctor any questions they have pertaining to this topic.

Timeline

Start date
2026-03-01
Primary completion
2027-07-30
Completion
2028-01-01
First posted
2026-03-23
Last updated
2026-03-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07488156. Inclusion in this directory is not an endorsement.